References
- Agarwal P Searls DB Can literature analysis identify innovation drivers in drug discovery? Nat Rev Drug Discov 2009 8 865 877 19876041
- Bordons M Bravo C Barrington S Time-tracking of the research profile of a drug using bibliometric tools J Am Soc Inf Sci Technol 2004 55 45 61
- Windsor DA Could bibliometric data be used to predict the clinical success of drugs? J Doc 1976 32 174 181
- Windsor DA Bibliometrics and drugs J Chem Inform Comput Sci 1980 20 4 255
- Kissin I Can a bibliometric indicator predict the success of an analgesic? Scientometrics 2011 86 785 795
- Kissin I The development of new analgesics over the past 50 years: a lack of real breakthrough drugs Anesth Analg 2010 110 780 789 20185657
- Stafford S Wagner TH Lavori PW New, but not improved? Incorporating comparative effectiveness information into FDA labeling N Eng J Med 2009 361 1230 1233
- Kissin I Bradley ELJr Top journal selectivity index: is it acceptable for drugs beyond the field of analgesia? Scientometrics 2011 88 589 597
- Koenig MED Determinants of expert judgment of research performance Scientometrics 1982 4 261 278
- Gagne JJ Choudhry NK How many “me-too” drugs is too many? JAMA 2011 305 711 721 21325189
- Kissin I Bradley ELJr Top journal selectivity index and “me-too” drugs Scientometrics 2012 91 131 142
- Cohen FJ Entry order as a consideration for innovation strategies Nat Rev Drug Discov 2006 5 285 293 16531989
- Angell M The Truth About the Drug Companies: How They Deceive Us and What to do About It New York, NY Random House 2004
- Curfman GD Morrissey S Drazen JM Products at risk N Engl J Med 2010 363 176
- Pekarsky B Should financial incentives be used to differentially reward “me-too” and innovative drugs? Pharmacoeconomics 2010 28 1 17 20014872
- DiMasi JA Faden LB Competitiveness in follow-on drug R&D: a race or imitation? Nat Rev Drug Discov 2011 10 23 27 21151030